Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem.

NCT02090855 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT02090855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02090855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem.
Lead sponsor
GE Healthcare
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
February 28, 2014
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment